Clinical Trial Update: A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial registry entry for a Phase 1/2a study of 23ME-00610 in patients with advanced solid malignancies, including several gynecologic cancers, renal ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Epithelial Ovarian Cancer
• Extensive-stage Small Cell Lung Cancer
• Fallopian Tube Cancer
• Neuroendocrine Tumors
• Peritoneal Carcinoma

Drugs mentioned

• 23ME-00610

Snippet

Sponsor: 23andMe, Inc. | Conditions: Solid Tumor, Clear Cell Renal Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING